Table 1.
Herpes Simplex Virus 2 Strains Used in Study
| Virus | Origin of parental isolate | Genotype | Paralysis dose50* |
| 186syn+-1 | United States | Wild type | 2.4 × 103 |
| G strain | United States | Wild type | 6.0 × 103 |
| 89-390 | United States | Wild type | 5.0 × 103 |
| SD90-3P | South Africa | Wild type | 3.0 × 103 |
| SD15 | South Africa | Wild type | 5.0 × 103 |
| SD66 | South Africa | Wild type | 1.0 × 103 |
| dl5-29 | United States | UL5, UL29 deletions | Not determined |
| 5B-lacZ | United States | UL29-lacZ fusion | Not determined |
| SD90-8LacZ | South Africa | UL29-lacZ fusion | Not determined |
NOTE. *Dose in plaque-forming units needed for 50% paralysis in Balb/c genital challenge model.